Alcoolature de Fenouil fruit
Food supplement declared in France, decision dated 21 November 2024
Alcoolature de Fenouil fruit (l'herbe vive) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- l'herbe vive
- Food business operator placing the product on the market
- Elodie BUTIN
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Compte-gouttes
- Daily dose
- 120 gouttes
- Directions for use
- 40 gouttes 2 à 3 fois par jour dans un peu d’eau, hors des repas. Agiter avant emploi.
- Intended populations
- Population générale
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous anticoagulants, Sous antidiabétiques, Ulcère (estomac ou duodenum)
- Objectives stated by the manufacturer (these are not authorised claims)
- Cycles féminins, Digestion
Declaration 2796, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Foeniculum vulgare Mill. | Fruit | Alcoolature | 540 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
déconseillé avant 12 ans, pendant la grossesse et l’allaitement, allergie croisée connue aux Apiacées (anis, céleri, etc.), au pollen d’armoise ou à l’anéthole. Prendre conseil auprès d’un professionnel de santé en cas de prise concomitante de médicament, de traitement antidiabétique, anticoagulant, d’ulcère gastrique ou d’hémophilie. Associer à une alimentation équilibrée et un mode de vie sain. Ne pas dépasser la dose recomandée. Tenir hors de portée des enfants.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Foeniculum vulgare Mill.
Read the warning, when it applies and the studies cited
BITTER FENNEL- FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Condition of application: Essential oil and Tincture.
Ask a health care practitioner before use if you are taking any medications including birth control pills or hormone therapy or other health products (EMA 2007).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024, 2007).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Health Canada monograph dated 29 November 2024
SWEET FENNEL -FOENICULUM VULGARE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (EMA 2024).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : l'herbe vive
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.